Correlation Between Talaris Therapeutics and Champions Oncology

Can any of the company-specific risk be diversified away by investing in both Talaris Therapeutics and Champions Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Talaris Therapeutics and Champions Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Talaris Therapeutics and Champions Oncology, you can compare the effects of market volatilities on Talaris Therapeutics and Champions Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Talaris Therapeutics with a short position of Champions Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Talaris Therapeutics and Champions Oncology.

Diversification Opportunities for Talaris Therapeutics and Champions Oncology

0.57

Correlation Coefficient

Talaris Therapeutics  Champions Oncology

Very weak diversification

The 3 months correlation between Talaris and Champions is 0.57. Overlapping area represents the amount of risk that can be diversified away by holding Talaris Therapeutics and Champions Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Champions Oncology and Talaris Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Talaris Therapeutics are associated (or correlated) with Champions Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Champions Oncology has no effect on the direction of Talaris Therapeutics i.e., Talaris Therapeutics and Champions Oncology go up and down completely randomly.

Pair Corralation between Talaris Therapeutics and Champions Oncology

If you would invest  459.00  in Champions Oncology on October 8, 2024 and sell it today you would earn a total of  515.00  from holding Champions Oncology or generate 112.2% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	1.61%
Values	Daily Returns

Talaris Therapeutics  vs.  Champions Oncology

Talaris Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Talaris Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable essential indicators, Talaris Therapeutics is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Champions Oncology

Risk-Adjusted Performance

19 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Champions Oncology are ranked lower than 19 (%) of all global equities and portfolios over the last 90 days. Even with relatively unfluctuating fundamental drivers, Champions Oncology reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Talaris Therapeutics and Champions Oncology

The main advantage of trading using opposite Talaris Therapeutics and Champions Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Talaris Therapeutics position performs unexpectedly, Champions Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Champions Oncology will offset losses from the drop in Champions Oncology's long position.

The idea behind Talaris Therapeutics and Champions Oncology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.